InformationInformation Center

23 2018-05
Application of Quadrivalent Influenza Vaccine (QIV)

Application of Quadrivalent Influenza Vaccine (QIV)

The Quadrivalent Influenza Vaccine developed by the Hualan Bio this time contains the above two influenza A and two influenza B antigens, covering more influenza epidemic types, which will effectively prevent and control influenza epidemic.

03 2018-05
Introduction of Shengming Bio

Introduction of Shengming Bio

Shengming Bio is wholly owned subsidiary of Hualan Group and can provide CRO and CMO services related to monoclonal antibody drugs that fully meet the requirements of CFDA/FDA.

06 2018-02
Situation Update in USA: Summary of Weekly FluView Activity Report

Situation Update in USA: Summary of Weekly FluView Activity Report

According to the latest FluView report, Influenza activity increased again in USA. The overall hospitalization rate is higher than the overall hospitalization rate reported during the same week of the 2014-2015 season; the most severe season in recent years.